Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Manitoba

$765,000.00

Development of an accurate, easy to use, dual marker GFR and ACR based, point-of-care test for rapid assessment of kidney health status

FY 2024-25

Summary
Chronic Kidney Disease (CKD) is a major health problem, affecting 10-14% of people around the world. CKD can lead to kidney failure, heart disease, disability, and even death. The good news is that CKD can be treated with medications which can slow or even stop the disease from getting worse. Measuring kidney function accurately and conveniently is essential to identify people who have CKD so that they can be treated, and to see how kidney function is responding to treatment. The goal of our project will be to build a small, easy to use, low cost test for measuring kidney function in health clinics, pharmacies, schools and potentially even at home. Our test will be light and small enough to take to smaller communities that don't have a lab. We will use a new method for measuring kidney function, called cystatin c, to improve accuracy. We plan to make accurate kidney testing as cheap and widely available as possible, with a goal of improving access to CKD diagnosis.
Program
Project Grant
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
522582
Name
Rigatto Claudio
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Commercialization
Projecttitle
Development of an accurate, easy to use, dual marker GFR and ACR based, point-of-care test for rapid assessment of kidney health status
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$765,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Biomarker Monitoring; Chronic Kidney Disease; Diagnostics; Kidney Function; Point Of Care; Risk Prediction
Abstract
Chronic Kidney Disease (CKD) is a major health problem, affecting 10-14% of people around the world. CKD can lead to kidney failure, heart disease, disability, and even death. The good news is that CKD can be treated with medications which can slow or even stop the disease from getting worse. Measuring kidney function accurately and conveniently is essential to identify people who have CKD so that they can be treated, and to see how kidney function is responding to treatment. The goal of our project will be to build a small, easy to use, low cost test for measuring kidney function in health clinics, pharmacies, schools and potentially even at home. Our test will be light and small enough to take to smaller communities that don't have a lab. We will use a new method for measuring kidney function, called cystatin c, to improve accuracy. We plan to make accurate kidney testing as cheap and widely available as possible, with a goal of improving access to CKD diagnosis.
Competitiondate
202503
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rigatto, Claudio
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $765,000~ $0~